Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.48 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.51.
Market Cap
8.48T
Revenue
4.52T
Profits
204.35B
PE Ratio
41.51
Profit Margin
4.52%
Dividend Yield
0.44%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 818.59B | 1.47% | 2,196,421 | 65.18B |
| 2 | AZN | AstraZeneca PLC | 580.49B | 0.73% | 1,483,523 | 58.74B |
| 3 | JNJ | Johnson & Johnson | 578.21B | 1.98% | 6,555,485 | 94.19B |
| 4 | ABBV | AbbVie Inc. | 366.33B | 0.96% | 6,164,279 | 61.16B |
| 5 | MRK | Merck & Co., Inc. | 295.13B | 2.58% | 10,377,711 | 65.01B |
| 6 | NVS | Novartis AG | 287.65B | 1.44% | 1,109,006 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 245.57B | -0.64% | 8,115,417 | 447.57B |
| 8 | AMGN | Amgen Inc. | 190.79B | 1.58% | 1,838,862 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 182.31B | 0.10% | 1,728,879 | 44.56B |
| 10 | ABT | Abbott Laboratories | 182.16B | 0.74% | 6,376,114 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 171.64B | 0.11% | 5,052,519 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 166.90B | -0.41% | 1,427,942 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 162.21B | -1.52% | 16,419,072 | 48.59B |
| 14 | PFE | Pfizer Inc. | 155.12B | 1.19% | 28,879,157 | 62.58B |
| 15 | DHR | Danaher Corporation | 132.34B | -1.55% | 5,265,181 | 24.57B |
| 16 | SYK | Stryker Corporation | 125.39B | -0.26% | 1,934,023 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.03B | 2.70% | 7,052,257 | 48.19B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 115.58B | 1.42% | 1,199,889 | 12.00B |
| 19 | MDT | Medtronic plc | 112.84B | 1.51% | 9,393,234 | 35.48B |
| 20 | SNY | Sanofi | 112.26B | 1.97% | 1,882,830 | 54.85B |
| 21 | GSK | GSK plc | 111.31B | 3.31% | 5,306,075 | 43.97B |
| 22 | HCA | HCA Healthcare, Inc. | 108.24B | -0.35% | 928,455 | 75.60B |
| 23 | MCK | McKesson Corporation | 107.76B | -0.25% | 669,449 | 397.96B |
| 24 | BSX | Boston Scientific Corporation | 103.55B | 2.39% | 9,438,591 | 20.07B |
| 25 | CVS | CVS Health Corporation | 91.83B | -0.85% | 5,363,232 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.23B | 1.05% | 552,806 | 14.34B |
| 27 | CI | The Cigna Group | 71.25B | 1.69% | 2,008,962 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 65.35B | 1.98% | 1,910,738 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.24B | -0.67% | 1,214,144 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.78B | 1.39% | 2,674,998 | 28.48B |
| 31 | MDLN | Medline Inc. | 56.06B | 1.52% | 5,286,226 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 49.72B | 1.97% | 1,326,175 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.27B | 0.67% | 3,245,097 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 48.01B | 1.20% | 3,639,305 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.84B | 0.97% | 419,828 | 4.30B |
| 36 | BDX | Becton, Dickinson and Company | 45.07B | 1.51% | 1,853,185 | 21.92B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.59B | 6.70% | 1,139,386 | 3.71B |
| 38 | HLN | Haleon plc | 43.38B | 0.41% | 8,376,089 | 14.85B |
| 39 | ARGX | argenx SE | 43.14B | 2.89% | 421,054 | 4.24B |
| 40 | ALC | Alcon Inc. | 36.68B | 1.37% | 995,054 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 33.87B | 1.10% | 8,167,641 | 17.26B |
| 42 | RMD | ResMed Inc. | 32.97B | -0.82% | 1,859,840 | 5.40B |
| 43 | GEHC | GE HealthCare Technologies Inc. | 32.91B | 1.75% | 3,562,317 | 20.63B |
| 44 | INSM | Insmed Incorporated | 31.97B | 6.59% | 1,986,620 | 606.42M |
| 45 | A | Agilent Technologies, Inc. | 31.93B | -1.07% | 1,704,164 | 7.07B |
| 46 | ONC | BeOne Medicines AG | 31.42B | 2.81% | 160,248 | 5.34B |
| 47 | WAT | Waters Corporation | 29.66B | 0.13% | 1,116,851 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 29.09B | -0.56% | 1,319,890 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 28.11B | -0.27% | 1,451,828 | 16.31B |
| 50 | BIIB | Biogen Inc. | 27.76B | 2.85% | 774,990 | 9.89B |
| 51 | NTRA | Natera, Inc. | 27.57B | 1.47% | 666,709 | 2.31B |
| 52 | PHG | Koninklijke Philips N.V. | 26.17B | 2.66% | 1,208,922 | 20.94B |
| 53 | MTD | Mettler-Toledo International Inc. | 25.73B | 0.10% | 124,129 | 4.03B |
| 54 | DXCM | DexCom, Inc. | 25.72B | 0.36% | 2,940,733 | 4.66B |
| 55 | UTHR | United Therapeutics Corporation | 23.74B | 1.84% | 534,684 | 3.18B |
| 56 | BNTX | BioNTech SE | 22.31B | 2.26% | 650,974 | 3.37B |
| 57 | LH | Labcorp Holdings Inc. | 21.92B | -0.04% | 474,918 | 13.95B |
| 58 | STE | STERIS plc | 21.91B | 0.74% | 691,995 | 5.83B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.61B | 0.19% | 679,643 | 11.04B |
| 60 | MRNA | Moderna, Inc. | 21.15B | 4.29% | 3,818,377 | 1.94B |
| 61 | HUM | Humana Inc. | 21.01B | 1.17% | 883,791 | 129.66B |
| 62 | RPRX | Royalty Pharma plc | 20.15B | 3.20% | 3,268,037 | 2.38B |
| 63 | EXAS | Exact Sciences Corporation | 20.03B | - | - | 3.25B |
| 64 | ROIV | Roivant Sciences Ltd. | 19.58B | 1.82% | 3,285,772 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 19.30B | 0.17% | 1,408,341 | 4.34B |
| 66 | RVMD | Revolution Medicines, Inc. | 18.69B | -1.29% | 2,483,407 | - |
| 67 | INCY | Incyte Corporation | 18.36B | 1.78% | 1,055,664 | 5.14B |
| 68 | WST | West Pharmaceutical Services, Inc. | 17.79B | 0.71% | 811,030 | 3.07B |
| 69 | THC | Tenet Healthcare Corporation | 17.40B | 0.21% | 482,296 | 21.31B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.37B | 1.53% | 1,738,197 | 8.23B |
| 71 | HOLX | Hologic, Inc. | 16.85B | -0.04% | 2,162,782 | 4.13B |
| 72 | CNC | Centene Corporation | 16.10B | -0.76% | 7,623,349 | 176.15B |
| 73 | GMAB | Genmab A/S | 15.90B | 1.16% | 3,153,183 | 3.72B |
| 74 | VTRS | Viatris Inc. | 15.54B | 1.05% | 5,749,999 | 14.30B |
| 75 | PODD | Insulet Corporation | 15.21B | -4.21% | 1,137,358 | 2.71B |
| 76 | COO | The Cooper Companies, Inc. | 13.94B | 1.36% | 2,049,652 | 4.15B |
| 77 | SMMT | Summit Therapeutics Inc. | 13.91B | 15.44% | 5,268,810 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.88B | 4.49% | 1,260,971 | 502.08M |
| 79 | SNN | Smith & Nephew plc | 13.78B | 0.90% | 426,078 | 6.16B |
| 80 | ASND | Ascendis Pharma A/S | 13.56B | 2.49% | 294,715 | 845.52M |
| 81 | MEDP | Medpace Holdings, Inc. | 13.25B | 1.32% | 397,801 | 2.53B |
| 82 | PEN | Penumbra, Inc. | 13.20B | 0.63% | 372,704 | 1.40B |
| 83 | NBIX | Neurocrine Biosciences, Inc. | 13.16B | 2.56% | 1,099,061 | 2.86B |
| 84 | ALGN | Align Technology, Inc. | 12.85B | 0.52% | 746,728 | 4.03B |
| 85 | ELAN | Elanco Animal Health Incorporated | 12.68B | 2.41% | 6,975,532 | 4.72B |
| 86 | FMS | Fresenius Medical Care AG | 12.43B | 1.04% | 361,084 | 23.05B |
| 87 | IONS | Ionis Pharmaceuticals, Inc. | 12.01B | 4.33% | 2,994,141 | 943.71M |
| 88 | RGC | Regencell Bioscience Holdings Limited | 11.94B | -1.13% | 53,050 | - |
| 89 | ENSG | The Ensign Group, Inc. | 11.85B | 0.48% | 406,717 | 5.06B |
| 90 | GMED | Globus Medical, Inc. | 11.80B | 1.28% | 717,522 | 2.94B |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.64B | 2.20% | 832,870 | 4.27B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.55B | 3.12% | 1,767,135 | 3.85B |
| 93 | UHS | Universal Health Services, Inc. | 11.41B | 0.43% | 651,801 | 17.36B |
| 94 | GH | Guardant Health, Inc. | 11.36B | 3.58% | 2,149,268 | 982.02M |
| 95 | SOLV | Solventum Corporation | 11.21B | 0.95% | 1,068,776 | 8.33B |
| 96 | EXEL | Exelixis, Inc. | 11.11B | 2.92% | 1,832,098 | 2.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | 2.77% | 1,946,894 | 3.22B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.60B | 3.80% | 303,498 | 958.40M |
| 99 | DVA | DaVita Inc. | 10.36B | 1.19% | 539,335 | 13.64B |
| 100 | EHC | Encompass Health Corporation | 9.82B | 1.36% | 666,066 | 5.94B |
| 101 | RVTY | Revvity, Inc. | 9.82B | 0.43% | 1,000,489 | 2.86B |
| 102 | MASI | Masimo Corporation | 9.57B | -0.34% | 1,019,958 | 1.53B |
| 103 | QGEN | Qiagen N.V. | 8.81B | 2.14% | 1,859,310 | 2.09B |
| 104 | BAX | Baxter International Inc. | 8.81B | 2.39% | 6,421,906 | 11.24B |
| 105 | ABVX | ABIVAX Société Anonyme | 8.69B | 0.48% | 782,371 | 5.37M |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 8.69B | 5.86% | 352,740 | 7.46M |
| 107 | BTSG | BrightSpring Health Services, Inc. | 8.67B | 3.49% | 3,980,871 | 12.91B |
| 108 | HSIC | Henry Schein, Inc. | 8.52B | 0.31% | 897,723 | 13.18B |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.51B | 8.00% | 3,389,561 | 1.09B |
| 110 | TEM | Tempus AI, Inc. | 8.36B | -4.24% | 4,436,742 | 1.27B |
| 111 | IBRX | ImmunityBio, Inc. | 8.30B | 8.83% | 28,079,357 | 113.29M |
| 112 | AXSM | Axsome Therapeutics, Inc. | 8.28B | 1.91% | 432,926 | 638.50M |
| 113 | TECH | Bio-Techne Corporation | 8.24B | 0.50% | 1,597,868 | 1.22B |
| 114 | CRL | Charles River Laboratories International, Inc. | 8.17B | 4.21% | 1,033,631 | 4.02B |
| 115 | ATR | AptarGroup, Inc. | 8.10B | 1.35% | 337,158 | 3.78B |
| 116 | PCVX | Vaxcyte, Inc. | 8.05B | 2.27% | 1,725,245 | - |
| 117 | NUVL | Nuvalent, Inc. | 7.70B | 1.92% | 636,906 | - |
| 118 | CYTK | Cytokinetics, Incorporated | 7.68B | 3.95% | 2,102,474 | 88.04M |
| 119 | ICLR | ICON Public Limited Company | 7.64B | -1.27% | 557,559 | 8.10B |
| 120 | HALO | Halozyme Therapeutics, Inc. | 7.46B | 1.93% | 882,029 | 1.40B |
| 121 | KRYS | Krystal Biotech, Inc. | 7.45B | 3.18% | 240,455 | 389.13M |
| 122 | BIO | Bio-Rad Laboratories, Inc. | 7.38B | 0.54% | 252,437 | 2.58B |
| 123 | MOH | Molina Healthcare, Inc. | 7.20B | -1.34% | 1,139,848 | 43.56B |
| 124 | HQY | HealthEquity, Inc. | 6.97B | 0.45% | 958,000 | 1.31B |
| 125 | ACLX | Arcellx, Inc. | 6.70B | -0.13% | 1,124,030 | 22.29M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.66B | 3.90% | 812,059 | 46.02M |
| 127 | KYMR | Kymera Therapeutics, Inc. | 6.44B | 6.06% | 934,873 | 39.21M |
| 128 | RGEN | Repligen Corporation | 6.44B | -1.70% | 1,479,795 | 738.26M |
| 129 | GKOS | Glaukos Corporation | 6.37B | 4.15% | 525,174 | 507.44M |
| 130 | BLTE | Belite Bio, Inc | 6.10B | 2.79% | 126,805 | - |
| 131 | AHG | Akso Health Group | 6.09B | 4.37% | 219,134 | 14.84M |
| 132 | COGT | Cogent Biosciences, Inc. | 5.92B | 4.41% | 2,298,208 | - |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | 2.46% | 1,154,426 | 189.76M |
| 134 | BLCO | Bausch + Lomb Corporation | 5.68B | 1.97% | 337,553 | 5.10B |
| 135 | CGON | CG Oncology, Inc. | 5.56B | 3.09% | 755,026 | 4.04M |
| 136 | PTCT | PTC Therapeutics, Inc. | 5.52B | 3.42% | 684,760 | 1.73B |
| 137 | APGE | Apogee Therapeutics, Inc. | 5.46B | 7.58% | 3,530,319 | - |
| 138 | BRKR | Bruker Corporation | 5.45B | -0.03% | 2,002,297 | 3.44B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 5.44B | 2.61% | 614,122 | 521.31M |
| 140 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 4.10% | 1,833,782 | 7.50M |
| 141 | AVTR | Avantor, Inc. | 5.25B | -0.52% | 5,005,727 | 6.55B |
| 142 | CAI | Caris Life Sciences, Inc. | 5.24B | -3.53% | 1,914,179 | 812.03M |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.22B | 7.40% | 1,715,180 | - |
| 144 | CHE | Chemed Corporation | 5.15B | 0.03% | 349,432 | 2.53B |
| 145 | PACS | PACS Group, Inc. | 5.13B | -3.26% | 713,296 | 5.29B |
| 146 | CELC | Celcuity Inc. | 5.10B | 8.05% | 849,928 | - |
| 147 | TGTX | TG Therapeutics, Inc. | 5.08B | 5.29% | 2,055,307 | 616.29M |
| 148 | IMVT | Immunovant, Inc. | 5.04B | 3.86% | 1,008,539 | - |
| 149 | ERAS | Erasca, Inc. | 4.97B | 9.00% | 5,661,133 | - |
| 150 | ALKS | Alkermes plc | 4.89B | 3.42% | 1,381,998 | 1.48B |
| 151 | LNTH | Lantheus Holdings, Inc. | 4.89B | 1.87% | 1,712,431 | 1.54B |
| 152 | TFX | Teleflex Incorporated | 4.78B | 1.52% | 666,487 | 1.99B |
| 153 | TERN | Terns Pharmaceuticals, Inc. | 4.76B | 5.72% | 79,399,134 | - |
| 154 | HIMS | Hims & Hers Health, Inc. | 4.75B | -2.34% | 21,664,660 | 2.35B |
| 155 | RDNT | RadNet, Inc. | 4.71B | 1.32% | 579,941 | 2.04B |
| 156 | WAY | Waystar Holding Corp. | 4.63B | 0.46% | 2,088,306 | 1.10B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.03% | 2,111,803 | 634.21M |
| 158 | CRSP | CRISPR Therapeutics AG | 4.52B | 1.42% | 1,079,194 | 3.51M |
| 159 | MMED | Minimed Group, Inc. | 4.50B | -1.84% | 667,218 | 2.89B |
| 160 | DOCS | Doximity, Inc. | 4.47B | -0.66% | 2,055,506 | 637.78M |
| 161 | OPCH | Option Care Health, Inc. | 4.46B | 0.28% | 1,249,145 | 5.65B |
| 162 | CORT | Corcept Therapeutics Incorporated | 4.30B | 19.66% | 11,407,933 | 761.41M |
| 163 | NVST | Envista Holdings Corporation | 4.28B | 0.42% | 1,690,137 | 2.72B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.08B | 1.44% | 140,303 | 268.09M |
| 165 | MMSI | Merit Medical Systems, Inc. | 4.05B | 0.83% | 667,049 | 1.52B |
| 166 | IRTC | iRhythm Holdings, Inc. | 3.94B | 2.61% | 636,763 | 747.14M |
| 167 | SHC | Sotera Health Company | 3.90B | -0.98% | 2,179,284 | 1.16B |
| 168 | STVN | Stevanato Group S.p.A. | 3.87B | -1.12% | 268,912 | 1.39B |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 3.86B | 1.57% | 1,791,899 | 3.02B |
| 170 | VKTX | Viking Therapeutics, Inc. | 3.84B | 3.20% | 1,906,701 | - |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | 5.73% | 1,246,208 | 7.70M |
| 172 | CNTA | Centessa Pharmaceuticals plc | 3.79B | 1.18% | 2,177,906 | 15.00M |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | 5.01% | 2,354,788 | 1.07B |
| 174 | OSCR | Oscar Health, Inc. | 3.64B | 1.50% | 6,714,423 | 11.70B |
| 175 | TMDX | TransMedics Group, Inc. | 3.61B | -3.48% | 1,567,744 | 605.49M |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.59B | 0.92% | 1,562,198 | 3.95B |
| 177 | SYRE | Spyre Therapeutics, Inc. | 3.59B | 8.20% | 667,731 | - |
| 178 | NAMS | NewAmsterdam Pharma Company N.V. | 3.57B | 3.16% | 740,818 | 22.50M |
| 179 | DNLI | Denali Therapeutics Inc. | 3.56B | 7.15% | 5,063,219 | - |
| 180 | DNTH | Dianthus Therapeutics, Inc. | 3.54B | 1.35% | 1,051,642 | 2.04M |
| 181 | BLLN | BillionToOne, Inc. | 3.54B | 3.94% | 236,524 | 305.11M |
| 182 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.51B | 2.00% | 381,032 | 677.56M |
| 183 | NNNN | Anbio Biotechnology | 3.47B | 3.92% | 16,969 | 6.92M |
| 184 | LIVN | LivaNova PLC | 3.46B | 1.44% | 532,410 | 1.39B |
| 185 | EWTX | Edgewise Therapeutics, Inc. | 3.43B | 4.24% | 767,749 | - |
| 186 | GPCR | Structure Therapeutics Inc. | 3.41B | 2.32% | 635,171 | - |
| 187 | BKD | Brookdale Senior Living Inc. | 3.29B | -0.93% | 2,541,788 | 3.05B |
| 188 | LEGN | Legend Biotech Corporation | 3.26B | 2.98% | 1,129,090 | 1.03B |
| 189 | ICUI | ICU Medical, Inc. | 3.24B | 1.53% | 278,271 | 2.23B |
| 190 | LQDA | Liquidia Corporation | 3.23B | 4.01% | 1,016,719 | 158.32M |
| 191 | HNGE | Hinge Health, Inc. | 3.17B | -1.76% | 758,681 | 587.86M |
| 192 | ALMS | Alumis Inc. | 3.16B | 7.54% | 1,852,821 | 24.05M |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.13B | 6.33% | 2,830,226 | - |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.02B | 1.48% | 125,710 | 803.79M |
| 195 | ITGR | Integer Holdings Corporation | 2.99B | 0.66% | 494,658 | 1.85B |
| 196 | TWST | Twist Bioscience Corporation | 2.98B | 2.42% | 1,943,206 | 391.56M |
| 197 | TNGX | Tango Therapeutics, Inc. | 2.98B | 7.19% | 4,365,650 | 62.38M |
| 198 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.91B | 3.16% | 1,006,297 | 588.99M |
| 199 | VRDN | Viridian Therapeutics, Inc. | 2.90B | 4.27% | 1,154,695 | 70.85M |
| 200 | PBH | Prestige Consumer Healthcare Inc. | 2.89B | -1.40% | 269,314 | 1.10B |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88B | 1.38% | 438,142 | 718.95M |
| 202 | VERA | Vera Therapeutics, Inc. | 2.87B | 1.03% | 1,411,425 | - |
| 203 | WRBY | Warby Parker Inc. | 2.86B | 1.39% | 1,369,487 | 871.91M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 2.85B | 6.03% | 414,562 | 451.36M |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.83B | 0.73% | 632,657 | 2.16B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 2.82B | 4.17% | 821,057 | 376.07M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 2.76B | 2.82% | 854,238 | 218.71M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.69B | 5.98% | 695,916 | 247.00M |
| 209 | TXG | 10x Genomics, Inc. | 2.67B | 5.55% | 2,734,009 | 642.82M |
| 210 | VCYT | Veracyte, Inc. | 2.61B | -0.46% | 609,761 | 517.15M |
| 211 | HAE | Haemonetics Corporation | 2.60B | -1.29% | 495,680 | 1.32B |
| 212 | LFST | LifeStance Health Group, Inc. | 2.59B | 3.10% | 1,893,700 | 1.42B |
| 213 | TVTX | Travere Therapeutics, Inc. | 2.54B | 2.87% | 1,569,742 | 490.73M |
| 214 | LMAT | LeMaitre Vascular, Inc. | 2.53B | 0.99% | 174,644 | 249.60M |
| 215 | PRVA | Privia Health Group, Inc. | 2.53B | -2.33% | 601,945 | 2.12B |
| 216 | NHC | National HealthCare Corporation | 2.51B | -0.35% | 84,200 | 1.52B |
| 217 | SRPT | Sarepta Therapeutics, Inc. | 2.50B | 34.98% | 17,059,636 | 2.20B |
| 218 | MANE | Veradermics, Incorporated | 2.45B | 3.26% | 427,988 | - |
| 219 | HCM | HUTCHMED (China) Limited | 2.43B | 0.28% | 10,748 | 548.51M |
| 220 | IRON | Disc Medicine, Inc. | 2.39B | 4.93% | 466,805 | - |
| 221 | HTFL | HeartFlow, Inc. | 2.38B | -0.79% | 1,197,262 | 176.03M |
| 222 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.36B | -2.69% | 7,087,667 | 874.84M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.35B | -3.47% | 5,328,910 | 139.74M |
| 224 | XRAY | DENTSPLY SIRONA Inc. | 2.33B | 1.88% | 2,955,547 | 3.68B |
| 225 | WVE | Wave Life Sciences Ltd. | 2.32B | 5.76% | 3,610,446 | 42.73M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.31B | -2.85% | 435,136 | 1.45B |
| 227 | PAHC | Phibro Animal Health Corporation | 2.31B | 2.76% | 480,554 | 1.46B |
| 228 | IMNM | Immunome, Inc. | 2.30B | 0.45% | 1,443,779 | 6.94M |
| 229 | ADMA | ADMA Biologics, Inc. | 2.29B | -15.00% | 32,462,904 | 510.17M |
| 230 | APLS | Apellis Pharmaceuticals, Inc. | 2.27B | 2.84% | 1,871,301 | 1.00B |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.24B | 7.14% | 3,278,486 | 3.31B |
| 232 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.05% | 1,816,645 | 158.18M |
| 233 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 1.80% | 1,879,147 | 276.98M |
| 234 | ORKA | Oruka Therapeutics, Inc. | 2.17B | 9.80% | 811,960 | - |
| 235 | GRAL | GRAIL, Inc. | 2.14B | 7.48% | 732,586 | 147.17M |
| 236 | SNDX | Syndax Pharmaceuticals, Inc. | 2.13B | 0.75% | 1,558,171 | 172.35M |
| 237 | ELVN | Enliven Therapeutics, Inc. | 2.12B | 14.06% | 6,431,135 | - |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 1.57% | 657,003 | 1.55M |
| 239 | AAPG | Ascentage Pharma Group International | 2.08B | 0.27% | 717 | 54.52M |
| 240 | NKTR | Nektar Therapeutics | 2.07B | -1.21% | 948,589 | 55.23M |
| 241 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | 7.60% | 970,081 | - |
| 242 | ZLAB | Zai Lab Limited | 2.02B | 4.69% | 552,913 | 460.16M |
| 243 | SEM | Select Medical Holdings Corporation | 2.02B | 0.12% | 1,365,203 | 5.45B |
| 244 | GLPG | Galapagos NV | 2.02B | 2.82% | 380,935 | 1.31B |
| 245 | MESO | Mesoblast Limited | 2.02B | 9.29% | 317,475 | 65.38M |
| 246 | STOK | Stoke Therapeutics, Inc. | 2.00B | 5.00% | 1,111,056 | 184.42M |
| 247 | NEOG | Neogen Corporation | 1.99B | 0.55% | 2,381,763 | 880.32M |
| 248 | TYRA | Tyra Biosciences, Inc. | 1.98B | 1.09% | 757,297 | - |
| 249 | WGS | GeneDx Holdings Corp. | 1.96B | -2.50% | 379,990 | 427.54M |
| 250 | RARE | Ultragenyx Pharmaceutical Inc. | 1.92B | 7.30% | 1,892,159 | 673.00M |
| 251 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | 1.13% | 979,477 | 283.06M |
| 252 | BHC | Bausch Health Companies Inc. | 1.88B | 1.80% | 1,114,339 | 10.27B |
| 253 | ANAB | AnaptysBio, Inc. | 1.88B | 3.76% | 284,023 | 234.60M |
| 254 | ADUS | Addus HomeCare Corporation | 1.85B | 0.01% | 213,377 | 1.42B |
| 255 | DFTX | Definium Therapeutics, Inc. | 1.84B | 3.82% | 2,357,787 | - |
| 256 | OCUL | Ocular Therapeutix, Inc. | 1.81B | 2.84% | 3,471,637 | 51.95M |
| 257 | ZYME | Zymeworks Inc. | 1.79B | 2.67% | 451,519 | 105.97M |
| 258 | MD | Pediatrix Medical Group, Inc. | 1.76B | 2.12% | 468,010 | 1.91B |
| 259 | ESTA | Establishment Labs Holdings Inc. | 1.75B | 2.42% | 525,234 | 211.08M |
| 260 | ATEC | Alphatec Holdings, Inc. | 1.74B | -2.21% | 1,593,491 | 764.16M |
| 261 | AGIO | Agios Pharmaceuticals, Inc. | 1.73B | 4.37% | 726,208 | 54.03M |
| 262 | AORT | Artivion, Inc. | 1.73B | 1.18% | 221,831 | 441.33M |
| 263 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 3.57% | 1,056,531 | 11.13M |
| 264 | RLAY | Relay Therapeutics, Inc. | 1.72B | 1.69% | 1,244,506 | 15.36M |
| 265 | INVA | Innoviva, Inc. | 1.67B | 3.06% | 568,273 | 411.33M |
| 266 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | - | 13,522,466 | 74.68M |
| 267 | SION | Sionna Therapeutics, Inc. | 1.67B | 6.67% | 285,593 | - |
| 268 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | 1.11% | 152,590 | 883.37M |
| 269 | TNDM | Tandem Diabetes Care, Inc. | 1.66B | -1.02% | 1,212,884 | 1.01B |
| 270 | SLNO | Soleno Therapeutics, Inc. | 1.64B | 1.60% | 1,264,192 | 190.41M |
| 271 | GRFS | Grifols, S.A. | 1.63B | 1.38% | 1,214,876 | 8.83B |
| 272 | VCEL | Vericel Corporation | 1.60B | -4.96% | 2,017,310 | 276.26M |
| 273 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | 1.81% | 558,512 | 868.45M |
| 274 | OGN | Organon & Co. | 1.59B | -0.16% | 3,054,837 | 6.22B |
| 275 | NRIX | Nurix Therapeutics, Inc. | 1.59B | 6.93% | 2,160,924 | 83.98M |
| 276 | OMCL | Omnicell, Inc. | 1.59B | 1.39% | 297,341 | 1.18B |
| 277 | MAZE | Maze Therapeutics, Inc. | 1.58B | -35.24% | 8,248,607 | 2.50M |
| 278 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 3.51% | 3,004,816 | 67.67M |
| 279 | SGRY | Surgery Partners, Inc. | 1.56B | 0.42% | 944,070 | 3.31B |
| 280 | AHCO | AdaptHealth Corp. | 1.55B | -0.78% | 1,531,379 | 3.24B |
| 281 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 3.59% | 9,945,024 | 263.50M |
| 282 | IMCR | Immunocore Holdings plc | 1.54B | 1.12% | 368,474 | 400.02M |
| 283 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.53B | 1.24% | 1,058,395 | -665.00K |
| 284 | NUVB | Nuvation Bio Inc. | 1.52B | 2.34% | 2,539,632 | 62.90M |
| 285 | NVAX | Novavax, Inc. | 1.52B | 0.86% | 2,441,872 | 1.12B |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.51B | 4.72% | 143,308 | - |
| 287 | GENB | Generate Biomedicines, Inc. | 1.51B | -1.66% | 472,815 | 31.89M |
| 288 | PLSE | Pulse Biosciences, Inc. | 1.50B | 3.43% | 206,893 | 350.00K |
| 289 | NBTX | Nanobiotix S.A. | 1.48B | 4.65% | 103,298 | 11.93M |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.48B | -1.01% | 661,162 | 336.39M |
| 291 | OCS | Oculis Holding AG | 1.48B | 1.96% | 323,374 | 1.51M |
| 292 | ATRC | AtriCure, Inc. | 1.47B | -0.27% | 334,254 | 534.53M |
| 293 | INSP | Inspire Medical Systems, Inc. | 1.47B | -1.27% | 632,293 | 911.98M |
| 294 | TRVI | Trevi Therapeutics, Inc. | 1.47B | 7.52% | 1,137,269 | - |
| 295 | UFPT | UFP Technologies, Inc. | 1.47B | 0.26% | 208,664 | 602.80M |
| 296 | PGNY | Progyny, Inc. | 1.45B | -1.66% | 1,226,426 | 1.29B |
| 297 | PHVS | Pharvaris N.V. | 1.44B | 3.83% | 80,804 | - |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | 0.15% | 902,015 | 2.43B |
| 299 | PVLA | Palvella Therapeutics, Inc. | 1.43B | 3.58% | 261,545 | - |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.41B | -0.64% | 927,226 | 308.05M |
| 301 | HCSG | Healthcare Services Group, Inc. | 1.38B | 1.65% | 430,005 | 1.84B |
| 302 | ARDX | Ardelyx, Inc. | 1.38B | 5.42% | 2,496,196 | 407.32M |
| 303 | RAPP | Rapport Therapeutics, Inc. | 1.38B | 2.23% | 305,565 | - |
| 304 | MBX | MBX Biosciences, Inc. | 1.38B | 4.10% | 337,181 | - |
| 305 | HROW | Harrow, Inc. | 1.35B | 3.27% | 523,060 | 272.30M |
| 306 | PRGO | Perrigo Company plc | 1.33B | 0.52% | 1,951,095 | 4.25B |
| 307 | NVCR | NovoCure Limited | 1.32B | 2.20% | 929,128 | 655.35M |
| 308 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | 10.90% | 3,144,525 | 9.77M |
| 309 | IMTX | Immatics N.V. | 1.31B | 5.87% | 807,667 | 56.67M |
| 310 | IRMD | IRADIMED CORPORATION | 1.30B | 0.80% | 53,889 | 83.81M |
| 311 | BHVN | Biohaven Ltd. | 1.30B | 2.62% | 1,596,683 | - |
| 312 | ENOV | Enovis Corporation | 1.29B | 2.31% | 628,251 | 2.25B |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.29B | 7.84% | 612,230 | - |
| 314 | ATAI | AtaiBeckley Inc. | 1.29B | 4.73% | 3,226,103 | 4.09M |
| 315 | ZBIO | Zenas BioPharma, Inc. | 1.27B | 5.37% | 467,862 | 10.00M |
| 316 | GLUE | Monte Rosa Therapeutics, Inc. | 1.26B | 6.73% | 1,319,223 | 123.67M |
| 317 | ARDT | Ardent Health, Inc. | 1.25B | 2.21% | 195,332 | 6.32B |
| 318 | VIR | Vir Biotechnology, Inc. | 1.25B | 4.90% | 2,439,946 | 68.56M |
| 319 | OLMA | Olema Pharmaceuticals, Inc. | 1.24B | 1.72% | 1,386,157 | - |
| 320 | ASTH | Astrana Health, Inc. | 1.21B | 1.92% | 267,480 | 3.18B |
| 321 | KOD | Kodiak Sciences Inc. | 1.21B | 4.12% | 758,709 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.20B | -0.58% | 377,564 | 83.72M |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | 8.14% | 1,299,415 | - |
| 324 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | 5.41% | 1,037,191 | - |
| 325 | CNMD | CONMED Corporation | 1.14B | 1.42% | 211,543 | 1.37B |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 0.35% | 88,235 | 773.34M |
| 327 | PHAR | Pharming Group N.V. | 1.11B | 1.63% | 13,287 | 376.13M |
| 328 | INNV | InnovAge Holding Corp. | 1.10B | 3.30% | 268,372 | 915.37M |
| 329 | PGEN | Precigen, Inc. | 1.10B | -0.96% | 6,697,359 | 9.68M |
| 330 | QDEL | QuidelOrtho Corporation | 1.09B | -0.99% | 2,004,536 | 2.73B |
| 331 | EYPT | EyePoint, Inc. | 1.09B | 3.65% | 687,426 | 31.37M |
| 332 | SEPN | Septerna, Inc. | 1.09B | 3.28% | 134,207 | 45.95M |
| 333 | SVRA | Savara Inc. | 1.08B | 4.76% | 1,648,762 | - |
| 334 | PNTG | The Pennant Group, Inc. | 1.08B | 0.29% | 182,755 | 947.71M |
| 335 | BFLY | Butterfly Network, Inc. | 1.06B | -1.18% | 5,191,772 | 97.61M |
| 336 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 0.06% | 652,633 | 780.57M |
| 337 | TVGN | Tevogen Bio Holdings Inc. | 1.05B | -0.77% | 28,443 | - |
| 338 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | 2.03% | 1,330,685 | 1.00B |
| 339 | ABCL | AbCellera Biologics Inc. | 1.03B | 2.42% | 1,583,955 | 75.13M |
| 340 | BCAX | Bicara Therapeutics Inc. | 1.02B | 2.86% | 364,879 | - |
| 341 | QURE | uniQure N.V. | 1.02B | 7.77% | 1,373,133 | 16.10M |
| 342 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.25% | 600,661 | 726.41M |
| 343 | NEO | NeoGenomics, Inc. | 1.01B | -1.15% | 1,267,850 | 727.33M |
| 344 | AZTA | Azenta, Inc. | 1.01B | 2.58% | 1,205,447 | 595.03M |
| 345 | GERN | Geron Corporation | 1.01B | 3.97% | 14,539,603 | 183.88M |
| 346 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 3.60% | 239,747 | - |
| 347 | CRON | Cronos Group Inc. | 999.63M | 1.55% | 777,514 | 146.59M |
| 348 | TDOC | Teladoc Health, Inc. | 993.67M | 2.77% | 3,910,763 | 2.53B |
| 349 | CMPX | Compass Therapeutics, Inc. | 988.68M | 3.00% | 1,004,808 | 850.00K |
| 350 | ALVO | Alvotech | 982.88M | 0.32% | 346,682 | 588.90M |
| 351 | AKTS | Aktis Oncology, Inc. | 979.02M | 0.05% | 270,611 | 5.56M |
| 352 | INBX | Inhibrx Biosciences, Inc. | 970.78M | 5.29% | 169,860 | 1.30M |
| 353 | CERT | Certara, Inc. | 970.75M | -2.40% | 3,416,319 | 418.84M |
| 354 | BLFS | BioLife Solutions, Inc. | 956.22M | 0.81% | 328,979 | 96.21M |
| 355 | SLS | SELLAS Life Sciences Group, Inc. | 951.79M | 6.11% | 5,298,912 | - |
| 356 | STAA | STAAR Surgical Company | 950.15M | 1.16% | 694,038 | 239.44M |
| 357 | SSII | SS Innovations International, Inc. | 944.57M | 0.62% | 27,438 | 42.48M |
| 358 | CDNA | CareDx, Inc. | 925.99M | 1.35% | 723,266 | 379.81M |
| 359 | XERS | Xeris Biopharma Holdings, Inc. | 913.89M | 0.19% | 2,406,776 | 291.85M |
| 360 | OPK | OPKO Health, Inc. | 913.56M | 5.31% | 3,126,903 | 606.88M |
| 361 | XNCR | Xencor, Inc. | 909.40M | 4.29% | 638,274 | 125.58M |
| 362 | EVO | Evotec SE | 894.87M | 7.69% | 134,584 | 887.40M |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 887.89M | 1.77% | 317,553 | 719.89M |
| 364 | ABUS | Arbutus Biopharma Corporation | 885.52M | 5.10% | 2,547,625 | 14.08M |
| 365 | CLOV | Clover Health Investments, Corp. | 883.85M | - | 3,214,133 | 1.92B |
| 366 | FTRE | Fortrea Holdings Inc. | 883.11M | -1.41% | 889,433 | 2.72B |
| 367 | URGN | UroGen Pharma Ltd. | 882.12M | 2.60% | 346,946 | 109.79M |
| 368 | INMD | InMode Ltd. | 871.18M | 0.36% | 829,400 | 370.50M |
| 369 | KALV | KalVista Pharmaceuticals, Inc. | 866.36M | 4.13% | 1,545,143 | 1.43M |
| 370 | TALK | Talkspace, Inc. | 857.10M | - | 10,458,456 | 228.87M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 851.00M | 3.08% | 1,159,483 | - |
| 372 | GHRS | GH Research PLC | 846.70M | 1.94% | 72,535 | - |
| 373 | SDGR | Schrödinger, Inc. | 841.61M | -1.47% | 814,820 | 255.87M |
| 374 | SGP | SpyGlass Pharma, Inc. | 840.27M | 6.23% | 72,582 | - |
| 375 | JANX | Janux Therapeutics, Inc. | 839.48M | 1.77% | 1,244,011 | 10.00M |
| 376 | IVA | Inventiva S.A. | 837.69M | - | 181,265 | 19.93M |
| 377 | EVMN | Evommune, Inc. | 833.10M | 10.04% | 448,876 | 13.00M |
| 378 | SANA | Sana Biotechnology, Inc. | 827.29M | 6.16% | 3,021,684 | - |
| 379 | PHAT | Phathom Pharmaceuticals, Inc. | 825.02M | 4.08% | 836,499 | 175.11M |
| 380 | TLRY | Tilray Brands, Inc. | 808.56M | 4.20% | 3,139,245 | 837.32M |
| 381 | PSNL | Personalis, Inc. | 805.67M | -1.03% | 1,145,220 | 69.65M |
| 382 | MPLT | MapLight Therapeutics, Inc. | 791.66M | 6.83% | 173,399 | - |
| 383 | ANL | Adlai Nortye Ltd. | 788.19M | 1.86% | 146,643 | -1.35M |
| 384 | TBPH | Theravance Biopharma, Inc. | 787.33M | 2.62% | 550,779 | 107.46M |
| 385 | SPRY | ARS Pharmaceuticals, Inc. | 784.45M | 4.77% | 1,868,754 | 84.28M |
| 386 | OMDA | Omada Health, Inc. | 763.67M | -3.28% | 692,855 | 260.21M |
| 387 | KURA | Kura Oncology, Inc. | 755.22M | 5.95% | 1,010,584 | 67.48M |
| 388 | CSTL | Castle Biosciences, Inc. | 751.31M | -0.32% | 270,323 | 344.23M |
| 389 | IART | Integra LifeSciences Holdings Corporation | 745.08M | 0.21% | 666,223 | 1.64B |
| 390 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 740.30M | 6.08% | 97,773 | - |
| 391 | OMER | Omeros Corporation | 740.20M | 2.55% | 633,120 | - |
| 392 | BIOA | BioAge Labs, Inc. | 728.27M | 1.86% | 575,173 | 9.00M |
| 393 | AMN | AMN Healthcare Services, Inc. | 725.64M | 2.16% | 718,680 | 2.73B |
| 394 | CTMX | CytomX Therapeutics, Inc. | 718.19M | -0.47% | 6,111,541 | 76.20M |
| 395 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -2.33% | 2,716,619 | 49.80M |
| 396 | SLDB | Solid Biosciences Inc. | 711.37M | 8.23% | 723,742 | - |
| 397 | ESPR | Esperion Therapeutics, Inc. | 708.80M | 5.34% | 4,589,160 | 403.14M |
| 398 | CBLL | CeriBell, Inc. | 706.53M | -0.79% | 225,027 | 89.06M |
| 399 | GDRX | GoodRx Holdings, Inc. | 705.70M | 0.98% | 1,349,121 | 796.85M |
| 400 | DRUG | Bright Minds Biosciences Inc. | 703.37M | 2.65% | 114,439 | - |
| 401 | MNKD | MannKind Corporation | 702.47M | -0.44% | 5,121,700 | 348.97M |
| 402 | NUTX | Nutex Health Inc. | 699.48M | 0.89% | 117,988 | 875.26M |
| 403 | RLMD | Relmada Therapeutics, Inc. | 698.57M | 9.18% | 1,651,321 | - |
| 404 | ARVN | Arvinas, Inc. | 698.45M | 6.12% | 547,472 | 262.60M |
| 405 | GYRE | Gyre Therapeutics, Inc. | 696.20M | 3.46% | 100,530 | 116.59M |
| 406 | EHAB | Enhabit, Inc. | 693.39M | 0.07% | 600,546 | 1.06B |
| 407 | JBIO | Jade Biosciences, Inc. | 687.96M | 5.20% | 375,033 | - |
| 408 | PHR | Phreesia, Inc. | 680.04M | - | 775,553 | 463.21M |
| 409 | DSGN | Design Therapeutics, Inc. | 661.74M | 4.07% | 317,782 | - |
| 410 | ANRO | Alto Neuroscience, Inc. | 660.31M | 2.38% | 186,075 | - |
| 411 | PRME | Prime Medicine, Inc. | 655.40M | 3.12% | 2,257,262 | 4.63M |
| 412 | ETON | Eton Pharmaceuticals, Inc. | 650.46M | 3.79% | 677,225 | 79.95M |
| 413 | ANNX | Annexon, Inc. | 641.83M | 7.30% | 2,172,912 | - |
| 414 | AVNS | Avanos Medical, Inc. | 641.75M | 1.10% | 414,718 | 701.20M |
| 415 | OCGN | Ocugen, Inc. | 639.40M | 1.56% | 12,266,447 | 4.41M |
| 416 | HSTM | HealthStream, Inc. | 629.11M | 1.12% | 272,446 | 304.06M |
| 417 | AGMB | AgomAb Therapeutics NV | 626.75M | 10.43% | 142,804 | - |
| 418 | REPL | Replimune Group, Inc. | 624.25M | 8.46% | 2,107,278 | - |
| 419 | DRTS | Alpha Tau Medical Ltd. | 621.35M | 0.71% | 205,328 | - |
| 420 | BVS | Bioventus Inc. | 617.09M | 0.11% | 341,168 | 568.09M |
| 421 | MGTX | MeiraGTx Holdings plc | 613.34M | 2.83% | 368,396 | 27.42M |
| 422 | LBRX | LB Pharmaceuticals Inc | 612.49M | 3.59% | 172,317 | - |
| 423 | MDXG | MiMedx Group, Inc. | 609.12M | -0.73% | 578,839 | 418.63M |
| 424 | TCMD | Tactile Systems Technology, Inc. | 604.95M | 0.37% | 306,485 | 329.52M |
| 425 | EIKN | Eikon Therapeutics, Inc. | 597.61M | 0.09% | 476,267 | - |
| 426 | CTKB | Cytek Biosciences, Inc. | 591.33M | -0.65% | 552,515 | 201.49M |
| 427 | TECX | Tectonic Therapeutic, Inc. | 583.20M | 3.29% | 204,359 | - |
| 428 | AXGN | Axogen, Inc. | 577.06M | 2.05% | 829,233 | 225.21M |
| 429 | SIBN | SI-BONE, Inc. | 570.17M | -1.97% | 464,760 | 200.93M |
| 430 | ALLO | Allogene Therapeutics, Inc. | 568.00M | 5.43% | 3,954,758 | 22.00K |
| 431 | VALN | Valneva SE | 561.87M | 0.93% | 371,660 | 205.07M |
| 432 | DBVT | DBV Technologies S.A. | 554.84M | 3.30% | 348,369 | 5.50M |
| 433 | YI | 111, Inc. | 543.70M | -1.02% | 22,725 | 1.91B |
| 434 | CMPS | COMPASS Pathways plc | 540.00M | 7.66% | 1,916,959 | - |
| 435 | YDES | YD Bio Limited | 538.65M | -0.91% | 21,822 | 510.36K |
| 436 | AVR | Anteris Technologies Global Corp. | 537.69M | 2.60% | 594,107 | 1.91M |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 536.04M | -0.22% | 620,054 | 106.47M |
| 438 | BNR | Burning Rock Biotech Limited | 534.98M | 2.47% | 134,450 | 77.14M |
| 439 | ZURA | Zura Bio Limited | 533.23M | 4.46% | 752,792 | - |
| 440 | EMBC | Embecta Corp. | 532.98M | -0.11% | 767,949 | 1.08B |
| 441 | CRMD | CorMedix Inc. | 522.52M | 2.32% | 918,101 | 311.71M |
| 442 | FLGT | Fulgent Genetics, Inc. | 520.61M | 2.02% | 890,601 | 322.67M |
| 443 | IRWD | Ironwood Pharmaceuticals, Inc. | 520.16M | 4.93% | 1,118,589 | 296.15M |
| 444 | CATX | Perspective Therapeutics, Inc. | 514.98M | 5.36% | 799,477 | 884.00K |
| 445 | AQST | Aquestive Therapeutics, Inc. | 513.81M | 8.51% | 1,750,611 | 44.55M |
| 446 | UPB | Upstream Bio, Inc. | 511.75M | 12.07% | 686,991 | 2.80M |
| 447 | RCKT | Rocket Pharmaceuticals, Inc. | 508.10M | 9.60% | 4,525,923 | - |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 504.39M | 7.63% | 895,581 | 85.21M |
| 449 | ADCT | ADC Therapeutics SA | 504.37M | 0.76% | 447,458 | 81.36M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 6.22M |
| 451 | BBNX | Beta Bionics, Inc. | 501.96M | 0.62% | 723,777 | 100.25M |
| 452 | PRTA | Prothena Corporation plc | 501.19M | 6.64% | 543,661 | 9.68M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 495.82M | 7.70% | 128,953 | - |
| 454 | NAUT | Nautilus Biotechnology, Inc. | 493.85M | -1.01% | 994,932 | - |
| 455 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 2.41% | 4,523,925 | - |
| 456 | RIGL | Rigel Pharmaceuticals, Inc. | 485.66M | 0.61% | 221,097 | 294.28M |
| 457 | OFIX | Orthofix Medical Inc. | 478.92M | 1.79% | 202,613 | 822.31M |
| 458 | ENGN | enGene Holdings Inc. | 473.62M | 2.46% | 114,308 | - |
| 459 | KMDA | Kamada Ltd. | 473.03M | - | 35,534 | 180.46M |
| 460 | IMMX | Immix Biopharma, Inc. | 471.91M | 3.97% | 768,669 | - |
| 461 | LYEL | Lyell Immunopharma, Inc. | 469.41M | 2.23% | 79,804 | 36.00K |
| 462 | FULC | Fulcrum Therapeutics, Inc. | 464.87M | 4.18% | 507,376 | 80.00M |
| 463 | ANGO | AngioDynamics, Inc. | 462.46M | 5.55% | 431,965 | 307.31M |
| 464 | TRDA | Entrada Therapeutics, Inc. | 461.33M | 5.06% | 136,335 | 25.42M |
| 465 | STTK | Shattuck Labs, Inc. | 455.86M | 4.08% | 621,134 | 1.00M |
| 466 | MRVI | Maravai LifeSciences Holdings, Inc. | 455.25M | 0.97% | 1,292,159 | 185.74M |
| 467 | NPCE | NeuroPace, Inc. | 454.84M | 1.81% | 280,767 | 99.99M |
| 468 | ASMB | Assembly Biosciences, Inc. | 454.78M | 1.56% | 58,346 | 72.30M |
| 469 | VREX | Varex Imaging Corporation | 447.91M | 0.66% | 190,262 | 854.40M |
| 470 | VSTM | Verastem, Inc. | 447.08M | 3.25% | 2,550,796 | 30.91M |
| 471 | ABSI | Absci Corporation | 446.82M | -2.99% | 7,133,683 | 2.80M |
| 472 | AUNA | Auna S.A. | 442.34M | 2.75% | 264,625 | 1.30B |
| 473 | IVVD | Invivyd, Inc. | 440.85M | 9.09% | 2,116,332 | 53.43M |
| 474 | MYGN | Myriad Genetics, Inc. | 437.62M | 1.52% | 1,482,105 | 824.50M |
| 475 | RGNX | REGENXBIO Inc. | 436.65M | 8.32% | 930,848 | 170.44M |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.23M | 2.76% | 154,061 | - |
| 477 | DNA | Ginkgo Bioworks Holdings, Inc. | 433.68M | 2.65% | 943,907 | 170.16M |
| 478 | ACRS | Aclaris Therapeutics, Inc. | 432.94M | 8.79% | 1,509,593 | 7.83M |
| 479 | AVIR | Atea Pharmaceuticals, Inc. | 432.62M | 1.88% | 372,979 | - |
| 480 | ALT | Altimmune, Inc. | 430.53M | 2.16% | 4,369,269 | 41.00K |
| 481 | VNDA | Vanda Pharmaceuticals Inc. | 428.53M | 6.30% | 1,257,624 | 216.11M |
| 482 | EBS | Emergent BioSolutions Inc. | 427.74M | 2.50% | 879,638 | 742.90M |
| 483 | NMRA | Neumora Therapeutics, Inc. | 417.72M | 1.21% | 766,186 | - |
| 484 | PACB | Pacific Biosciences of California, Inc. | 417.52M | - | 2,923,207 | 160.01M |
| 485 | LXEO | Lexeo Therapeutics, Inc. | 417.49M | 4.00% | 719,343 | - |
| 486 | AURA | Aura Biosciences, Inc. | 411.50M | 2.69% | 213,021 | - |
| 487 | KIDS | OrthoPediatrics Corp. | 410.27M | 2.01% | 210,208 | 236.35M |
| 488 | CYH | Community Health Systems, Inc. | 407.56M | 0.68% | 842,845 | 12.49B |
| 489 | NRC | National Research Corporation | 390.78M | -1.49% | 66,922 | 137.39M |
| 490 | STRO | Sutro Biopharma, Inc. | 389.25M | -0.32% | 467,080 | 102.48M |
| 491 | CV | CapsoVision, Inc. | 387.39M | -4.83% | 465,879 | 13.09M |
| 492 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | 4.73% | 1,573,934 | 14.56M |
| 493 | PRTC | PureTech Health plc | 382.24M | 1.11% | 340 | 6.39M |
| 494 | SRTA | Strata Critical Medical, Inc. | 381.01M | 1.74% | 771,862 | 197.14M |
| 495 | MNPR | Monopar Therapeutics Inc. | 380.57M | 3.08% | 250,860 | - |
| 496 | LAB | Standard BioTools Inc. | 375.25M | 1.27% | 1,233,690 | 85.33M |
| 497 | BNTC | Benitec Biopharma Inc. | 372.40M | 1.31% | 83,535 | - |
| 498 | AKBA | Akebia Therapeutics, Inc. | 372.35M | 2.21% | 1,864,167 | 236.20M |
| 499 | IPSC | Century Therapeutics, Inc. | 372.03M | -7.59% | 1,054,974 | 109.16M |
| 500 | XFOR | X4 Pharmaceuticals, Inc. | 371.86M | 7.07% | 402,498 | 35.11M |